Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hayward G. et al, (2024), Journal of Infection, 88
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020
Inclusion and diversity in the PRINCIPLE trial
Patel MG. et al, (2021), The Lancet, 397, 2251 - 2252